Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.4728

+0.0128 (2.78%)

Aug 14, 2025, 11:45 AM - Market open

RVPH Employees

Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.

Employees

14

Change (1Y)

-1

Growth (1Y)

-6.67%

Revenue / Employee

n/a

Profits / Employee

-$2,065,574

Market Cap

32.15M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	14	-1	-6.67%
Dec 31, 2023	15	5	50.00%
Dec 31, 2022	10	5	100.00%
Dec 31, 2021	5	0	-
Dec 31, 2020	5	1	25.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

RVPH News

7 weeks ago - Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewsWire
7 weeks ago - Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewsWire
2 months ago - Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewsWire
2 months ago - Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia - GlobeNewsWire
3 months ago - Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
4 months ago - Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress - GlobeNewsWire
6 months ago - Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
7 months ago - Reviva to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewsWire